Clinical trial
Effectiveness and Safety of Campath in Combination With Tacrolimus Monotherapy…
NCT00147381 · Dr. Claudia Bösmüller, Other · Completed
Key facts
| NCT number | NCT00147381 |
|---|---|
| Title | Effectiveness and Safety of Campath in Combination With Tacrolimus Monotherapy to Prevent Kidney Graft Rejection |
| Official title | Effectiveness and Safety of Campath-1H as an Induction Agent in Combination With Tacrolimus Monotherapy for Prevention of Graft Rejection Compared to Tacrolimus in Combination With MMF and Steroids in Cadaveric Kidney Transplantation |
| Lead sponsor | Dr. Claudia Bösmüller, Other |
| Collaborators | Astellas Pharma GmbH Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Transplantation |
| Intervention type | Drug |
| Interventions | Alemtuzumab, Tacrolimus |
| Enrollment | 197 |
| Start date | Jan 1, 2004 |
| Primary completion | Aug 1, 2008 |
| Completion | Jul 1, 2011 |
| First posted | Sep 7, 2005 |
| Last update posted | Jun 19, 2012 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: